Literature DB >> 20728531

Strategies for high-level recombinant protein expression in transgenic microalgae: a review.

Gabriel Potvin1, Zisheng Zhang.   

Abstract

Microalgae represent the 'best of both worlds', combining the high growth rate and ease of cultivation of microorganisms with the ability to perform post-transcriptional and post-translational modifications of plants. The development of economically viable microalgal expression systems is, however, hindered by low recombinant protein yields. Although there are still many obstacles to overcome before microalgae become standard expression systems, considerable progress has been made in recent years in regards to elucidating the causes for these low yields and in the development of strategies to improve them. Transgenes have successfully been expressed in both nuclear and chloroplast microalgal genomes, although at economically viable levels only in the latter. The present review describes recent progress in genetic manipulation of microalgae, outlines strategies to increase protein yields and presents some interesting avenues of research that remain to be explored.
Copyright © 2010 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20728531     DOI: 10.1016/j.biotechadv.2010.08.006

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  33 in total

1.  Haematococcus as a promising cell factory to produce recombinant pharmaceutical proteins.

Authors:  Amir Ata Saei; Parisa Ghanbari; Abolfazl Barzegari
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

Review 2.  The transgenic animal platform for biopharmaceutical production.

Authors:  L R Bertolini; H Meade; C R Lazzarotto; L T Martins; K C Tavares; M Bertolini; J D Murray
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

3.  Microalgae as platforms for production of recombinant proteins and valuable compounds: progress and prospects.

Authors:  Yangmin Gong; Hanhua Hu; Yuan Gao; Xudong Xu; Hong Gao
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-01       Impact factor: 3.346

Review 4.  The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins.

Authors:  Fariba Akbari; Morteza Eskandani; Ahmad Yari Khosroushahi
Journal:  World J Microbiol Biotechnol       Date:  2014-08-13       Impact factor: 3.312

Review 5.  Eukaryotic microalgae as hosts for light-driven heterologous isoprenoid production.

Authors:  Kyle J Lauersen
Journal:  Planta       Date:  2018-11-22       Impact factor: 4.116

Review 6.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

Review 7.  Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives.

Authors:  Sergio Rosales-Mendoza; Luz María Teresita Paz-Maldonado; Ruth Elena Soria-Guerra
Journal:  Plant Cell Rep       Date:  2011-11-12       Impact factor: 4.570

8.  Recombinant Protein Production and Purification of Insoluble Proteins.

Authors:  Neus Ferrer-Miralles; Paolo Saccardo; José Luis Corchero; Elena Garcia-Fruitós
Journal:  Methods Mol Biol       Date:  2022

9.  The Entry Blocker Peptide Produced in Chlamydomonas reinhardtii Inhibits Influenza Viral Replication in vitro.

Authors:  Karen Lizbeth Reyes-Barrera; Ruth Elena Soria-Guerra; Rogelio López-Martínez; Leonor Huerta; Nohemí Salinas-Jazmín; Carlos Cabello-Gutiérrez; Ángel Gabriel Alpuche-Solís
Journal:  Front Plant Sci       Date:  2021-05-12       Impact factor: 5.753

10.  Application of synthetic biology in cyanobacteria and algae.

Authors:  Bo Wang; Jiangxin Wang; Weiwen Zhang; Deirdre R Meldrum
Journal:  Front Microbiol       Date:  2012-09-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.